Liposomes as vehicles for enhancing drug delivery via skin routes

被引:46
|
作者
Fang, JY
Hwang, TL
Huang, YL
机构
[1] Chang Gung Univ, Pharmaceut Lab, Grad Inst Nat Prod, Taoyuan 333, Taiwan
[2] Chang Gung Univ, Cell Pharmacol Lab, Grad Inst Nat Prod, Taoyuan 333, Taiwan
关键词
liposomes; skin; drug delivery; stratum corneum;
D O I
10.2174/157341306775473791
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The delivery of drugs via skin routes has been extensively investigated. Nevertheless, clinical applications are limited by the stratum corneum (SC), the predominant barrier of the skin. One of the possibilities for increasing skin absorption or permeation of drugs is the use of nano/submicron vesicular systems. Classic liposomes are of little value as carriers for drug delivery via the skin because they do not deeply penetrate it. Only specially designed liposomes have been shown to be capable of achieving enhanced delivery. Liposomes are tiny spheres ranging in diameter from 50 nm to several microns. This review article explores the types and mechanisms involved with liposomes with nanostructures for enhancing topical or transdermal drug delivery. The incorporation of some additives such as anionic surfactants and ethanol can fluidize the phospholipid bilayers, thus increasing the depths to which liposomes can penetrate into the intercellular pathways of the skin. Hair follicles are also important for the enhancement of transdermal liposomes. Niosomes, non-ionic surfactant vesicles, are alternatives to liposomes, which are also discussed in this review. Physical methods such as iontophoresis, ultrasound, and tape-stripping can further assist the delivery of drugs encapsulated in liposomes. Recent breakthroughs with liposomes are beneficial to topically applied permeants, especially for dermatological medications, cosmetic ingredients, and protein/peptide macromolecules.
引用
收藏
页码:55 / 70
页数:16
相关论文
共 50 条
  • [21] Exploring the utility of hybrid siloxane-phosphocholine (SiPC) liposomes as drug delivery vehicles
    Frampton, Mark B.
    Blais, Andrea
    Raczywolski, Zachary
    Castle, Alan
    Zelisko, Paul M.
    RSC ADVANCES, 2021, 11 (21) : 13014 - 13023
  • [22] Liposomes as drug delivery systems
    Clark, AP
    CANCER PRACTICE, 1998, 6 (04) : 251 - 253
  • [23] Liposomes - Opportunities in drug delivery
    Allen, TM
    DRUGS, 1997, 54 (Suppl 4) : 8 - 14
  • [24] LIPOSOMES FOR THE DRUG DELIVERY OF CARBORANES
    Olusanya, Temidayo
    NEURO-ONCOLOGY, 2013, 15 : 61 - 61
  • [25] Liposomes for drug delivery in stroke
    Bruch, Gisele E.
    Fernandes, Lorena F.
    Bassi, Beatriz L. T.
    Alves, Marco Tullio R.
    Pereira, Isabelle O.
    Frezard, Frederic
    Massensini, Andre R.
    BRAIN RESEARCH BULLETIN, 2019, 152 : 246 - 256
  • [26] DRUG DELIVERY USING LIPOSOMES
    ASSERAF, P
    GAZETTE MEDICALE, 1990, 97 (28): : 11 - 15
  • [27] Characterizing Liposomes for Drug Delivery
    Carnell, Pauline
    Kaszuba, Mike
    R&D MAGAZINE, 2014, 56 (02): : 16 - 17
  • [28] LIPOSOMES IN TOPICAL DRUG DELIVERY
    SCHAEFFER, HE
    KROHN, DL
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1982, 22 (02) : 220 - 227
  • [29] LIPOSOMES AS A DRUG DELIVERY SYSTEM
    JULIANO, RL
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1981, 2 (02) : 39 - 42
  • [30] LIPOSOMES AS A DRUG DELIVERY SYSTEM
    WEINER, N
    MARTIN, F
    RIAZ, M
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1989, 15 (10) : 1523 - 1554